InvestorsHub Logo
Followers 8
Posts 522
Boards Moderated 0
Alias Born 01/19/2015

Re: None

Wednesday, 01/21/2015 4:16:47 PM

Wednesday, January 21, 2015 4:16:47 PM

Post# of 334
My thoughts, BUY, WF10 top line results are to be released mid-February as per Nuvo NR.

Nuvo Research currently sitting on $5 CASH per share, no debt, revenue generating drugs plus potential blockbuster drug WF10.

Again, my thoughts, BUY, this stock is on sale based on the big picture.